Giant Biogene (2367 HK)

167

Analysis

Consumer Staples • China

Giant Biogene designs, develops, manufactures, and sells beauty and health products, primarily functional skincare products and medical dressings, utilizing recombinant collagen as a key bioactive ingredient. The company also develops and manufactures functional foods based on rare ginsenosides technology. It was founded in 2000 and is headquartered in Xi'an, People's Republic of China.

Refresh

Exchange Announcement • 24 Sep 2026 17:27

Interim Report 2026

Exchange Announcement • 18 Aug 2026 18:00

Announcement Of Interim Results For The Six Months Ended 30 June 2026

Exchange Announcement • 05 Aug 2026 16:34

Date Of Board Meeting

Exchange Announcement • 17 Jun 2026 16:31

Voluntary Announcement

Exchange Announcement • 28 May 2026 21:13

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Interim Report 2026

Announcement Of Interim Results For The Six Months Ended 30 June 2026

Date Of Board Meeting

Voluntary Announcement

Supplemental Announcement In Relation To The Proposed Change Of Auditors